MYRON Z. HOLUBIAK - 12 Dec 2024 Form 4 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Role
Secretary, Director
Signature
/s/ Lorna A. Knick, by Power of Attorney
Issuer symbol
CTOR
Transactions as of
12 Dec 2024
Net transactions value
$0
Form type
4
Filing time
16 Dec 2024, 16:09:06 UTC
Previous filing
12 Nov 2024
Next filing
12 Aug 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTOR Stock Option (Right to Buy) Award $0 +300,000 $0.000000 300,000 12 Dec 2024 Common Stock 300,000 $1.07 Direct F1
transaction CTOR Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 12 Dec 2024 Common Stock 50,000 $1.07 See footnote F2
holding CTOR Stock Option (Right to Buy) 1,500,000 12 Dec 2024 Common Stock 1,500,000 $2.15 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date.
F2 These options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
F3 These options vest over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services Continuous Service to the Company as of each such vesting date.